ClinicalTrials.gg
RecruitingNCT07434583Updated Feb 25, 2026

Force Sensor Study

An interventional study of Direct laryngoscopy force modulation and Direct laryngoscopy without force modulation in Laryngeal Disease, Post-operative Pain and Tongue Injury, sponsored by University of California, San Francisco. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-25.

Sponsored by University of California, San Francisco · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 72 studies in Laryngeal Diseases with a site in United States — 15 open to participants now, 17 under way, 3 of them phase 3. Laryngeal Diseases · United States.

Planned enrollment
10th of 61
100 · median 46
Started
2026
with 4 others
No phase
16 of 72
4 open now
Primary completion
2027-01
later than 1 of 16 live
Registered
67th of 72
by date

Among the 72 studies in Laryngeal Diseases with a site in United States, this one is the 10th largest by planned enrollment of the 61 interventional ones that give a count, is one of 5 that started in 2026, is one of 16 with no phase, reaches primary completion later than 1 of the 16 other live ones, and was the 67th registered.

Laryngeal Diseases

147 studies on the registry are indexed under Laryngeal Diseases; 26 are open to participants now.

Browse Laryngeal Diseases studies →

Open to participants now

15 of the 72 studies in Laryngeal Diseases with a site in United States are open now. Recruiting first, the newest first:

9 more — sign in →

All 15 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 21 Laryngeal Diseases studies recruiting now, 17 (81%) set no upper age limit and 1 (5%) stops at 75 or younger; 3 take children under 18; 2 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 72 studies in Laryngeal Diseases with a site in United States, or all of them as a file.
02

Study summary

This research is to understand more about the forces that are involved on the tongue and other oropharyngeal structures during laryngeal surgery. This information will be used to determine if these forces can affect outcomes (pain, numbness, taste, etc) and whether factors such as procedure type, surgeon experience (i.e. resident, fellow, attending), and choice of surgical equipment affect these forces. This information may be used to reduce these forces and prevent these issues from happening during certain laryngeal surgeries.

For the first 50 patients, force measurements will be taken and correlated to outcome measures . Surgeons will be blinded to the force measurements intra-operatively.

For the next 50 patients, surgeons will be given force measurements in real-time intra-operatively allowing adjustments to be made. The impact of this adjustment on outcomes will be determined.

03

Conditions studied

  • Laryngeal Disease
  • Post-operative Pain
  • Tongue Injury
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • >18 years old with
  • undergoing laryngeal surgery with direct laryngoscopy

Exclusion criteria

Exclusion Criteria:

  • Prior history of tongue dysfunction such as glossectomy (hemi or total) or hypoglossal nerve injury
  • Patient inability to follow up after initial procedure
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Factorial assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Active comparator
    Surgeon blinded

    Patients will undergo direct laryngoscopy with force measurements taken intra-operatively. Post-operative outcome measures will be collected.

    Procedure: Direct laryngoscopy without force modulation

  • Experimental
    Surgeon unblinded

    Patients will undergo direct laryngoscopy with force measurements taken intra-operatively. The surgeon will be aware of force measurements in real-time, allowing for adjustments to reduce applied force during direct laryngoscopy. Post-operative outcome measures will be collected.

    Procedure: Direct laryngoscopy force modulation

Interventions

  • ProcedureDirect laryngoscopy force modulation

    Modification of applied force during direct laryngoscopy using real-time force sensor measurements.

  • ProcedureDirect laryngoscopy without force modulation

    Patients will undergo direct laryngoscopy as is done in standard of care without active modulation of applied force

06

What researchers measure

Primary outcomes

  1. Short Form McGill Pain Questionnaire (SF-MPQ)

    The SF-MPQ includes the following components: 15 descriptors: * 11 sensory, each rated 0=none, 1=mild, 2=moderate, 3=severe * 4 affective , each rated 0=none, 1=mild, 2=moderate, 3=severe. A Present Pain Intensity (PPI) scale (0=No Pain, 1=Mild, 2=Discomforting, 3=Distressing, 4=Horrible, 5=Excruciating) Visual Analogue Scale of average pain (VAS, 0-10 cm) - higher score is worse pain

    Time frame: 1 day, 14 days, and 1 month post-operatively

Secondary outcomes

  1. Tongue mobility

    Assessment of changes in tongue mobility post-operatively. My physician report Tongue deviation is: 0 - absent 1 - present

    Time frame: 1 month post-operatively

  2. Tongue sensation

    Assessment of changes in tongue sensation post-operatively, according to patient report: My tongue numbness is: 0 - absent 1. \- minimal 2. \- mild 3. \- moderatre 4. \- severe

    Time frame: 1 day, 14 days, and 1 month post-operatively

  3. Change in taste

    Assessment of changes in taste post-operatively, according to patient report: My tongue numbness is: 0 - absent 1 - minimal 2 - mild 3 - moderatre 4 - severe

    Time frame: 1 day, 14 days, 1 month post-operatively

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Jan 2027, 12 months after the start.

Of 29 interventional studies with no phase under Laryngeal Diseases, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 52. This study's planned 12 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 6, 2026
First posted
Feb 25, 2026
StartActual
Jan 2, 2026
Primary completionEst.
Jan 31, 2027
CompletionEst.
Jan 31, 2027
Last update
Feb 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07434583
Responsible party
Sponsor
First posted
Feb 25, 2026
Start date
Jan 2, 2026
Primary completion
Jan 31, 2027 (estimated)
Completion
Jan 31, 2027 (estimated)
Last update
Feb 25, 2026

Study contacts

Riley Jackson
Contact
riley.jackson@ucsf.edu
6282526882
Tyler Crosby, MD
principal investigator · University of California, San Francisco

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion